Valuation dashboard for Medline Inc. (MDLN) with P/E 60.22, P/B 4.50, EV/EBITDA 18.3 and dividend yield 0.00%. DCF, Graham Number, EPS growth, peer multiples and dividend discount models plus sector comparison against other Healthcare companies.
Medline Inc. is a global manufacturer of medical and surgical products, catering to a broad spectrum of healthcare providers. Their clientele includes hospitals, surgical centers, physician practices, post-acute care facilities, and nursing homes, both domestically and worldwide. The company's operations are divided into two primary divisions: the Medline Brand and Supply Chain Solutions.
Where would it trade at its usual multiples?
Versus its usual multiples: expensive · Current P/E 60.2× · Multiples range: $20.56 · $20.56.
At its sector median (30.7×) $21 (-49%). Implied price from applying the reference multiples to today's earnings (or book value, or FFO) per share. Not a fair value: it is where the stock would trade at its usual multiples.
Analysis Summary
Trailing-twelve-month margins: gross margin 25.2%, operating margin 5.7%, net margin 2.2%.
At $40.35 (closing price, November 4, 2026), MDLN trades at a P/E of 60.22 and an ROE of 6.06%. Market capitalisation stands at $35.4B, placing it among large-cap names.
Balance sheet quality for MDLN: debt-to-equity ratio of 0.00, current ratio of 4.04 over the last 12 months. A debt-to-equity below 1.0 typically signals conservative capital structure, while a current ratio above 1.5 indicates comfortable short-term liquidity.
Valuation Ratios
| P/E Ratio | 60.22 |
| Price / Book | 4.50 |
| EV / EBITDA | 18.3 |
| Dividend Yield | 0.00% |
Peer Comparison
| Symbol | Company | Market Cap | P/E | P/B | ROE |
|---|---|---|---|---|---|
| MDLN | Medline Inc. | $35.4B | 60.22 | 4.50 | 6.1% |
| COO | The Cooper Companies, Inc. | $12.2B | 21.99 | 1.50 | 6.9% |
| MMSI | Merit Medical Systems, Inc. | $5.4B | 34.07 | 3.11 | 9.7% |
| ICUI | ICU Medical, Inc. | $4.3B | 146.29 | 2.01 | 1.4% |
| BDX | Becton, Dickinson and Company | $57.0B | 63.01 | 2.35 | 3.8% |
| SOLV | Solventum Corporation | $15.2B | 10.91 | 3.23 | 29.0% |
| TFX | Teleflex Incorporated | $6.4B | 2.25 | -31.8% |
Price
| Price | $40.35 (closing price, November 4, 2026) |
| Market Cap | $35.4B |
| Exchange | NASDAQ |
| Country | US |
Profitability
| Return on Equity | 6.06% |
| Return on Invested Capital | 3.68% |
| Return on Assets | 1.71% |
| Gross Margin | 25.16% |
| Operating Margin | 5.68% |
| Net Margin | 2.24% |
Related companies: COO · MMSI · ICUI · BDX · SOLV · TFX
Explore sector: Healthcare · Medical - Instruments & Supplies
More sections of MDLN: Overview · Financials · Estimates · Technical · Ownership
Discover more: Weekly Radar: the S&P 500 through the Buffett and Lynch methods · Companies that pass the Buffett method · Companies that pass the Lynch method · Stocks that pass Graham's defensive investor test today · Investment Academy — learn to analyze stocks